Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [906]
News [2550]
Articles [106]
Editorials [3]
Conferences [84]
elearning [20]
Cdk1 inhibition sensitises tumours with wild type BRCA1 to PARP inhibition
Cdk1 inhibition sensitises tumours with wild type BRCA1 to PARP inhibition
Integrated analyses of the ovarian cancer genome
Integrated analyses of the ovarian cancer genome
NICE turns down eroltinib for non-small-cell-lung-cancer
NICE turns down eroltinib for non-small-cell-lung-cancer
Bevacizumab unlikely to be effective with brain metastases
Bevacizumab unlikely to be effective with brain metastases
Worse cancer outcomes in deprived UK areas highlighted
Worse cancer outcomes in deprived UK areas highlighted
Just under half of deaths in men with prostate cancer due to the disease
Just under half of deaths in men with prostate cancer due to the disease
Cancer performance in England 'lags behind other countries'
Cancer performance in England 'lags behind other countries'
Chemokine CCL2 recruits inflammatory monocytes to facilitate breast tumour metastasis
Chemokine CCL2 recruits inflammatory monocytes to facilitate breast tumour metastasis
Addition of cetuximab to oxaliplatin-based chemotherapy in advanced colorectal cancer: Results from the COIN trial
Addition of cetuximab to oxaliplatin-based chemotherapy in advanced colorectal cancer: Results from the COIN trial
ASCO 2011: Extending pemetrexed treatment as maintenance therapy improves progression-free survival for advanced lung cancer
ASCO 2011: Extending pemetrexed treatment as maintenance therapy improves progression-free survival for advanced...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation